REGN logo

REGN Non current assets

Annual non current assets:

$19.10B+$5.50B(+40.42%)
December 31, 2024

Summary

  • As of today (May 29, 2025), REGN annual long term assets is $19.10 billion, with the most recent change of +$5.50 billion (+40.42%) on December 31, 2024.
  • During the last 3 years, REGN annual non current assets has risen by +$7.68 billion (+67.24%).
  • REGN annual non current assets is now at all-time high.

Performance

REGN Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

quarterly non current assets:

$19.97B+$875.00M(+4.58%)
March 31, 2025

Summary

  • As of today (May 29, 2025), REGN quarterly long term assets is $19.97 billion, with the most recent change of +$875.00 million (+4.58%) on March 31, 2025.
  • Over the past year, REGN quarterly non current assets has increased by +$4.48 billion (+28.88%).
  • REGN quarterly non current assets is now at all-time high.

Performance

REGN quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

REGN Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.4%+28.9%
3 y3 years+67.2%+65.9%
5 y5 years+168.4%+180.8%

REGN Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+67.2%at high+71.1%
5 y5-yearat high+168.4%at high+204.1%
alltimeall timeat high>+9999.0%at high>+9999.0%

REGN Non current assets History

DateAnnualQuarterly
Mar 2025
-
$19.97B(+4.6%)
Dec 2024
$18.66B(-4.2%)
$19.10B(+5.5%)
Sep 2024
-
$18.11B(+6.5%)
Jun 2024
-
$17.01B(+9.7%)
Mar 2024
-
$15.50B(+13.9%)
Dec 2023
$19.48B(+22.6%)
$13.60B(+0.5%)
Sep 2023
-
$13.53B(-1.5%)
Jun 2023
-
$13.73B(+4.4%)
Mar 2023
-
$13.15B(-1.3%)
Dec 2022
$15.88B(+13.3%)
$13.33B(+8.8%)
Sep 2022
-
$12.25B(+4.9%)
Jun 2022
-
$11.68B(-3.0%)
Mar 2022
-
$12.04B(+5.5%)
Dec 2021
$14.01B(+43.3%)
$11.42B(+15.4%)
Sep 2021
-
$9.90B(+21.4%)
Jun 2021
-
$8.15B(+5.6%)
Mar 2021
-
$7.72B(+4.5%)
Dec 2020
$9.78B(+27.2%)
$7.38B(+5.7%)
Sep 2020
-
$6.99B(+6.4%)
Jun 2020
-
$6.57B(-7.7%)
Mar 2020
-
$7.11B(-0.0%)
Dec 2019
$7.69B(+19.3%)
$7.12B(+4.2%)
Sep 2019
-
$6.83B(+4.7%)
Jun 2019
-
$6.52B(+10.1%)
Mar 2019
-
$5.93B(+12.1%)
Dec 2018
$6.45B(+48.7%)
$5.29B(+3.9%)
Sep 2018
-
$5.09B(-1.0%)
Jun 2018
-
$5.14B(+6.4%)
Mar 2018
-
$4.83B(+9.0%)
Dec 2017
$4.33B(+36.3%)
$4.43B(-3.0%)
Sep 2017
-
$4.57B(+7.5%)
Jun 2017
-
$4.25B(+2.4%)
Mar 2017
-
$4.15B(+9.4%)
Dec 2016
$3.18B(+9.1%)
$3.79B(+14.0%)
Sep 2016
-
$3.33B(+11.0%)
Jun 2016
-
$3.00B(+8.1%)
Mar 2016
-
$2.77B(+2.9%)
Dec 2015
$2.92B(+39.8%)
$2.69B(+7.4%)
Sep 2015
-
$2.51B(+11.8%)
Jun 2015
-
$2.24B(+18.8%)
Mar 2015
-
$1.89B(+7.7%)
Dec 2014
$2.08B(+16.0%)
$1.75B(+13.9%)
Sep 2014
-
$1.54B(+0.1%)
Jun 2014
-
$1.54B(+10.7%)
Mar 2014
-
$1.39B(+20.4%)
Dec 2013
$1.80B(+49.0%)
$1.15B(+14.7%)
Sep 2013
-
$1.01B(+23.2%)
Jun 2013
-
$816.90M(-15.7%)
Mar 2013
-
$968.88M(+10.8%)
Dec 2012
$1.21B(+81.1%)
$874.48M(+22.8%)
Sep 2012
-
$712.01M(+3.4%)
Jun 2012
-
$688.31M(+5.4%)
Mar 2012
-
$653.24M(-0.7%)
Dec 2011
$665.78M(+86.2%)
$657.81M(+2.3%)
Sep 2011
-
$643.16M(+1.5%)
Jun 2011
-
$633.59M(-15.4%)
Mar 2011
-
$748.79M(+2.3%)
Dec 2010
$357.62M(-16.0%)
$731.81M(+99.6%)
Sep 2010
-
$366.71M(-1.7%)
Jun 2010
-
$372.89M(-4.8%)
Mar 2010
-
$391.71M(+24.1%)
Dec 2009
$425.51M(-18.4%)
$315.69M(+12.5%)
Sep 2009
-
$280.60M(+1.2%)
Jun 2009
-
$277.31M(+40.3%)
Mar 2009
-
$197.63M(-2.5%)
Dec 2008
$521.44M
$202.78M(+83.8%)
Sep 2008
-
$110.35M(+1.4%)
Jun 2008
-
$108.83M(-24.1%)
DateAnnualQuarterly
Mar 2008
-
$143.37M(+3.6%)
Dec 2007
$797.83M(+69.8%)
$138.43M(-8.4%)
Sep 2007
-
$151.08M(+49.8%)
Jun 2007
-
$100.88M(-10.1%)
Mar 2007
-
$112.27M(-2.5%)
Dec 2006
$469.98M(+37.7%)
$115.11M(+41.3%)
Sep 2006
-
$81.44M(-6.7%)
Jun 2006
-
$87.28M(+5.9%)
Mar 2006
-
$82.44M(+0.4%)
Dec 2005
$341.39M(-0.7%)
$82.11M(-12.9%)
Sep 2005
-
$94.32M(+7.6%)
Jun 2005
-
$87.64M(-12.7%)
Mar 2005
-
$100.44M(-22.2%)
Dec 2004
$343.95M(+7.4%)
$129.15M(-20.0%)
Sep 2004
-
$161.45M(+54.0%)
Jun 2004
-
$104.84M(-7.9%)
Mar 2004
-
$113.89M(-28.5%)
Dec 2003
$320.21M(+15.6%)
$159.35M(+65.8%)
Sep 2003
-
$96.12M(-4.3%)
Jun 2003
-
$100.40M(-0.3%)
Mar 2003
-
$100.70M(-12.1%)
Dec 2002
$276.95M(-29.7%)
$114.63M(+9.4%)
Sep 2002
-
$104.77M(-19.9%)
Jun 2002
-
$130.75M(-3.0%)
Mar 2002
-
$134.75M(+33.1%)
Dec 2001
$394.19M(+193.9%)
$101.21M(+53.6%)
Sep 2001
-
$65.89M(-21.1%)
Jun 2001
-
$83.51M(+33.5%)
Mar 2001
-
$62.55M(-15.6%)
Dec 2000
$134.14M(+83.8%)
$74.13M(-6.5%)
Sep 2000
-
$79.32M(+22.7%)
Jun 2000
-
$64.65M(+10.4%)
Mar 2000
-
$58.55M(-8.5%)
Dec 1999
$73.00M(-21.4%)
$64.00M(+6.3%)
Sep 1999
-
$60.20M(-5.3%)
Jun 1999
-
$63.60M(-13.0%)
Mar 1999
-
$73.10M(+14.2%)
Dec 1998
$92.90M(-6.7%)
$64.00M(-12.6%)
Sep 1998
-
$73.20M(-4.6%)
Jun 1998
-
$76.70M(+8.8%)
Mar 1998
-
$70.50M(+2.5%)
Dec 1997
$99.60M(+17.2%)
$68.80M(+9.9%)
Sep 1997
-
$62.60M(+5.4%)
Jun 1997
-
$59.40M(+3.8%)
Mar 1997
-
$57.20M(+8.7%)
Dec 1996
$85.00M(+72.8%)
$52.60M(-8.0%)
Sep 1996
-
$57.20M(-0.7%)
Jun 1996
-
$57.60M(+20.8%)
Mar 1996
-
$47.70M(+7.0%)
Dec 1995
$49.20M(-5.4%)
$44.60M(+2.3%)
Sep 1995
-
$43.60M(-0.7%)
Jun 1995
-
$43.90M(-8.9%)
Mar 1995
-
$48.20M(+14.2%)
Dec 1994
$52.00M(-43.4%)
$42.20M(-16.3%)
Sep 1994
-
$50.40M(0.0%)
Jun 1994
-
$50.40M(-17.9%)
Mar 1994
-
$61.40M(+138.0%)
Dec 1993
$91.80M(+8.4%)
$25.80M(+58.3%)
Sep 1993
-
$16.30M(+10.9%)
Jun 1993
-
$14.70M(+6.5%)
Mar 1993
-
$13.80M(+4.5%)
Dec 1992
$84.70M(-20.5%)
$13.20M(+5.6%)
Sep 1992
-
$12.50M(+10.6%)
Jun 1992
-
$11.30M(+15.3%)
Mar 1992
-
$9.80M(+32.4%)
Dec 1991
$106.60M(+375.9%)
$7.40M(+68.2%)
Sep 1991
-
$4.40M(+12.8%)
Jun 1991
-
$3.90M(+30.0%)
Dec 1990
$22.40M
$3.00M

FAQ

  • What is Regeneron Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual non current assets year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?

What is Regeneron Pharmaceuticals annual long term assets?

The current annual non current assets of REGN is $19.10B

What is the all time high annual non current assets for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual long term assets is $19.10B

What is Regeneron Pharmaceuticals annual non current assets year-on-year change?

Over the past year, REGN annual long term assets has changed by +$5.50B (+40.42%)

What is Regeneron Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of REGN is $19.97B

What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly long term assets is $19.97B

What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, REGN quarterly long term assets has changed by +$4.48B (+28.88%)
On this page